A bill to require the Attorney General to make a determination as to whether cannabidiol should be a controlled substance and listed in a schedule under the Controlled Substances Act and to expand research on the potential medical benefits of cannabidiol and other marijuana components.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Senior Senator for California. Democrat.
Last Updated: Jul 14, 2016
Length: 12 pages
Jul 14, 2016
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on July 14, 2016, in a previous session of Congress, but was not enacted.
Jul 14, 2016
May 25, 2017
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 1276.
S. 3269 (114th) was a bill in the United States Congress.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
Civic Impulse. (2018). S. 3269 — 114th Congress: Cannabidiol Research Expansion Act. Retrieved from https://www.govtrack.us/congress/bills/114/s3269
“S. 3269 — 114th Congress: Cannabidiol Research Expansion Act.” www.GovTrack.us. 2016. March 18, 2018 <https://www.govtrack.us/congress/bills/114/s3269>
|title=S. 3269 (114th)
|accessdate=March 18, 2018
|author=114th Congress (2016)
|date=July 14, 2016
|quote=Cannabidiol Research Expansion Act